WO2001056541A1 - Kosmetische zubereitungen mit waltheria indica extrakte - Google Patents

Kosmetische zubereitungen mit waltheria indica extrakte Download PDF

Info

Publication number
WO2001056541A1
WO2001056541A1 PCT/EP2001/000884 EP0100884W WO0156541A1 WO 2001056541 A1 WO2001056541 A1 WO 2001056541A1 EP 0100884 W EP0100884 W EP 0100884W WO 0156541 A1 WO0156541 A1 WO 0156541A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
oil
fatty
extracts
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/000884
Other languages
German (de)
English (en)
French (fr)
Inventor
Marc Pauly
Philippe Moser
Véronique Gillon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Health and Care Products France SAS
Original Assignee
Cognis France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis France SAS filed Critical Cognis France SAS
Priority to KR1020027010186A priority Critical patent/KR100748056B1/ko
Priority to BR0108056-3A priority patent/BR0108056A/pt
Priority to JP2001556233A priority patent/JP2003521505A/ja
Priority to EP20010916957 priority patent/EP1253906B1/de
Priority to DE50104294T priority patent/DE50104294D1/de
Priority to AU44111/01A priority patent/AU4411101A/en
Publication of WO2001056541A1 publication Critical patent/WO2001056541A1/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Definitions

  • Melanin is a black pigment that is found in the skin and hair and is produced enzymatically in the melanosomes from the amino acid tyrosine.
  • Melanosomes are components of melanocytes, a type of cell found in the junction between the dermis and epidermis.
  • the enzyme tyrosinase is responsible for the formation of melanin from tyrosine. While in many cases the formation of melanin in the sense of skin tanning is at least to a certain extent desired by the consumer, there is also a need for the opposite effect.
  • a skin bass is a special beauty feature that is associated with the absence of physical work outdoors and therefore with a certain social status. In individual cases, however, it can simply be a matter of removing age spots or freckles.
  • the invention relates to cosmetic preparations containing
  • Component (a) according to the invention is produced by customary methods of extracting the plants or parts of plants.
  • suitable conventional extraction methods such as maceration, remaceration, digestion, movement maceration, vortex extraction, ultrasound extraction, countercurrent extraction, percolation, repercolation, evacolation (extraction under reduced pressure), diacolation and solid-liquid extraction under continuous reflux , which is carried out in a Soxhlet extractor, which is familiar to a person skilled in the art and in principle all can be used, for the sake of simplicity, for example, on Hager's Handbook of Pharmaceutical Practice, (5th edition, vol. 2, pp. 1026-1030, Springer Verlag , Berlin-Heidelberg-New-York 1991).
  • Fresh plants or parts of plants can be used as the starting material, but usually from dried plants and / or parts of plants, which can be mechanically comminuted before extraction, are suitable here all comminution methods known to the person skilled in the art, for example grinding milling.
  • Organic solvents water (preferably distilled hot water at a temperature) can be used as the solvent for carrying out the extractions above 80 ° C and in particular between 85 and 90 ° C) or mixtures of organic solvents and water, in particular low molecular weight alcohols with more or less high water contents, are particularly preferred extraction with methanol, ethanol, pentane, hexane, heptane, Acetone, propylene glycols, polyethylene glycols as well as ethyl acetate and mixtures thereof and their water-based mixtures.
  • the extracts thus produced can be subjected, for example, to a selective separation of individual undesirable ingredients.
  • the extraction can be carried out up to any Degree of extraction take place, but is usually carried out until exhaustion.
  • the ocher leaves are in the range from 0.5 to 10% by weight, in particular from 1 to 5% by weight.
  • the present invention encompasses the knowledge that the extraction conditions and the yields of the final extracts can be chosen by the person skilled in the art according to the desired field of use Extracts are then subjected, for example, to spray or freeze drying
  • ferulic acid (synonym: 4-hydroxy-3-methoxycinnamic acid, caffeic acid 3-methyl ether) as a tyrosinase inhibitor is reported, for example, in the international patent application WO 99/37280 (Unilever); an overview can also be found in PhiuZ 14, 115 (1985).
  • Another object of the present invention relates to the use of mixtures containing
  • the degree of oligomerization is a statistical mean value which is based on a homolog distribution customary for such technical products
  • suitable Partialgiyce ⁇ de are Hydroxysteannsauremonoglycend, steannsaurediglyce ⁇ d hydroxy, Isosteannsauremonoglycerid, Isosteannsaurediglyce ⁇ d, Olsauremonoglycend, Olsaurediglyce ⁇ d, Ricinolsauremoglycend, Ricinolsaurediglycend, Linolsauremonoglycend, Linolsaure- diglyce ⁇ d, ünolensauremonoglyce ⁇ d, Linolensaurediglycend, Erucasauremonoglyce ⁇ d, Erucasaure- diglyce ⁇ d, ⁇ d Weinsauremonoglyce ⁇ d, Weinsaurediglyce ⁇ d, Citron
  • Suitable thickeners are, for example, aerosil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyiosis, carboxymethyl cellulose and hydroxyethyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates , (eg Carbopole® and Pemulen types from Goodrich; Synthalene® from Sigma; Keltrol types from Kelco; Sepigel types from Seppic; Saicare types from Allied Colloids), polyacrylamides, polymers, polyvinyl alcohol and polyvinyl pyrrolidone, surfactants such as, for example, ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as, for example, pentaerythnate or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or
  • the pigments can also be surface-treated, ie hydrophilized or hydrophobicized.
  • Typical examples are coated titanium dioxides, such as titanium dioxide T 805 (Degussa) or Eusolex® T2000 (Merck).
  • the most hydrophobic coating agents are silicones and, in particular, T ⁇ al - koxyoctylsilane or simethicone in question So-called micro- or nano-pigments are preferably used in sunscreens. Micronized zinc oxide is preferably used.
  • Further suitable UV light protection filters can be found in the overview by P Fmkel in S ⁇ FW-Journal 122, 543 (1996) and Perfumery and Cosmetics 3 ( 1999), page 11ff
  • Suitable as odor absorbers are substances that absorb and largely retain odor-forming compounds.You can reduce the partial pressure of the individual components and thus also reduce their rate of expansion.It is important that perfumes must remain unaffected. Odor absorbers have no activity against bacteria.For example, they contain a complex zinc salt as the main component Ricmoleic acid or special, largely odorless fragrances known to the person skilled in the art as "fixators", such as extracts from labdanum or styrax or certain abietic acid derivatives. Odorants or perfume oils act as odor suppressors and, in addition to their function as odor eliminators, act as deodorants for the respective deodorants Giving a fragrance note As perfumes, for example, mixtures of natural and synthetic fragrances.
  • Natural fragrances are extracts of bleeds, stems and leaves. Fruits Fruit peel, roots, wood, Kr Autern and grazers, needles and twigs as well as resins and balsams. Animal raw materials are also suitable, such as civet and castoreum. Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type.
  • Fragrance compounds are of the ester type eg benzyl acetate, p-tert-butylcyclohexyl acetate, linalyl acetate, phenylethyl acetate, lmalyl benzoate, benzyl formate, allyl cyclohexyl propionate, styrallyl propionate and benzyl salicylate
  • ethers include benzyl ethyl ether, for the aldehydes alkali atoms z. Citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal, to the ketones e.g.
  • Usable film formers for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinyl pyrrolidone, vinyl pyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or compounds thereof and the like
  • Methyl compounds such as in particular trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;
  • the ethers include, for example, benzylethylether, the aldehydes, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetalonone, lilydialonaldehyde, cyclamenaldehyde, cyclamenaldehyde, cyclamenaldehyde, cyclamenaldehyde, cyclamenaldehyde, cyclamenaldehyde, cyclamenaldehyde, cyclamen
  • the hydrocarbons mainly include the terpenes and balsams, but mixtures of different fragrances
  • perfume oils e.g. sage oil, camomile oil, clove oil, melissa oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiverol, oliban oil, galbanumol L abolanumol and lavandin
  • perfume oils e.g. sage oil, camomile oil, clove oil, melissa oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiverol, oliban oil, galbanumol L abolanumol and lavandin
  • sage oil e.g. sage oil, camomile oil, clove oil, melissa oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiverol, oliban oil, galbanumol L abolanumol and lavandin
  • sage oil e.g. sage oil, camomile oil, clove oil, melissa oil, mint
  • the dyes which can be used are those which are suitable and approved for cosmetic purposes, such as are listed, for example, in the publication "Cosmetic Dyes” by the Dye Commission of the German Research Foundation, Verlag Chemie, Weinheim, 1984, pp. 81-106. These dyes are usually used in concentrations from 0.001 to 0.1% by weight, based on the mixture as a whole
  • the brown colored extract was obtained at an initial temperature of 185 ° C and a final temperature of 80 ° C, optionally after adding an auxiliary such as mannitol (1/2 auxiliary, 1/2 extracted material or 1/10 excipient and 9/10 extracted material) spray dried.
  • an auxiliary such as mannitol (1/2 auxiliary, 1/2 extracted material or 1/10 excipient and 9/10 extracted material) spray dried.
  • Table 1 Information on alcoholic and aqueous-alcoholic extracts from Waltheria indica

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PCT/EP2001/000884 2000-02-07 2001-01-27 Kosmetische zubereitungen mit waltheria indica extrakte Ceased WO2001056541A1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
KR1020027010186A KR100748056B1 (ko) 2000-02-07 2001-01-27 월터리아 인디카 추출물을 함유하는 화장품 제제
BR0108056-3A BR0108056A (pt) 2000-02-07 2001-01-27 Preparados cosméticos com extratos waltheria indica
JP2001556233A JP2003521505A (ja) 2000-02-07 2001-01-27 Waltheriaindica抽出物を含有する化粧品製剤
EP20010916957 EP1253906B1 (de) 2000-02-07 2001-01-27 Kosmetische zubereitungen mit waltheria indica extrakten und ferulasäure
DE50104294T DE50104294D1 (de) 2000-02-07 2001-01-27 Kosmetische zubereitungen mit waltheria indica extrakten und ferulasäure
AU44111/01A AU4411101A (en) 2000-02-07 2001-01-27 Cosmetic preparations containing waltheria indica extracts

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00440033A EP1121926A1 (de) 2000-02-07 2000-02-07 Kosmetische Zubereitungen mit Waltheria Indica Extrakte
EP00440033.9 2000-02-07

Publications (1)

Publication Number Publication Date
WO2001056541A1 true WO2001056541A1 (de) 2001-08-09

Family

ID=8174095

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/000884 Ceased WO2001056541A1 (de) 2000-02-07 2001-01-27 Kosmetische zubereitungen mit waltheria indica extrakte

Country Status (10)

Country Link
US (1) US20030152536A1 (enExample)
EP (2) EP1121926A1 (enExample)
JP (1) JP2003521505A (enExample)
KR (1) KR100748056B1 (enExample)
CN (1) CN1398179A (enExample)
AU (1) AU4411101A (enExample)
BR (1) BR0108056A (enExample)
DE (1) DE50104294D1 (enExample)
ES (1) ES2231464T3 (enExample)
WO (1) WO2001056541A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10148827B4 (de) * 2001-10-04 2004-12-09 Beiersdorf Ag Ascorbinsäurehaltige O/W-Emulsionen, diese enthaltende kosmetische und/oder dermatologische Zubereitungen, deren Verwendung sowie Verfahren zu ihrer Herstellung
EP1742710B1 (en) 2004-01-13 2009-06-03 L'Oréal USA Creative, Inc. Stabilized ascorbic acid compositions and methods therefor
KR20070097092A (ko) * 2005-01-14 2007-10-02 리포 케미컬즈 인크. 과다색소침착된 피부 치료용 조성물 및 치료방법
DE102005013380A1 (de) * 2005-03-23 2006-10-05 Merck Patent Gmbh Extraktionsverfahren
US20070225360A1 (en) 2006-03-22 2007-09-27 L'oreal Anti-aging composition containing phloretin
EP1842530A1 (en) * 2006-03-23 2007-10-10 Cognis IP Management GmbH Cosmetic composition comprising a combination of a sugar fatty acid ester with a plant extract of waltheria indica or pisum sativum for skin whitening
JP4638963B2 (ja) * 2008-04-07 2011-02-23 敏 新川 痩身用化粧品組成物
EP2480090B1 (en) 2009-09-24 2013-11-06 Unilever NV Disinfecting agent comprising eugenol, terpineol and thymol
WO2012076310A1 (en) 2010-12-07 2012-06-14 Unilever Nv An oral care composition
US9693941B2 (en) 2011-11-03 2017-07-04 Conopco, Inc. Liquid personal wash composition
US9072919B2 (en) 2012-10-12 2015-07-07 L'oreal S.A. Synergistic antioxidant cosmetic compositions containing at least one of baicalin and taxifolin, at least one of caffeine and nicotinamide, at least one of vitamin C and resveratrol and ferulic acid
CN103070804B (zh) * 2013-01-28 2014-12-10 朱进仓 祛痘净肤液
CN103740511B (zh) * 2013-12-16 2015-04-22 张圣坤 一种飞扬草药皂
EP2960235B1 (de) * 2014-06-25 2018-09-26 Symrise AG Tetrahydrofuranderivate als riechstoffe
CN105379824A (zh) * 2015-10-08 2016-03-09 盐城工学院 一种抑制酪氨酸酶的出芽短梗霉发酵大米液制备方法
CN105581919B (zh) * 2015-11-26 2018-09-18 北京工商大学 阿魏酸磷脂复合物及其在制备具有美白功效的化妆品中的用途
CN108902153B (zh) * 2018-08-10 2020-04-28 海南大学 一种广谱植物源杀菌剂及其制备方法和应用
WO2021253053A1 (en) * 2020-06-12 2021-12-16 Mary Kay Inc. Topical compositions and methods

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998055087A1 (fr) * 1997-06-06 1998-12-10 Laboratoires Serobiologiques Produit cosmetique comprenant des extraits de plantes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06256137A (ja) * 1993-03-01 1994-09-13 Chugai Pharmaceut Co Ltd 美白用皮膚外用剤
GB9801597D0 (en) * 1998-01-26 1998-03-25 Unilever Plc Skin lightening composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998055087A1 (fr) * 1997-06-06 1998-12-10 Laboratoires Serobiologiques Produit cosmetique comprenant des extraits de plantes

Also Published As

Publication number Publication date
KR20030005184A (ko) 2003-01-17
CN1398179A (zh) 2003-02-19
ES2231464T3 (es) 2005-05-16
EP1253906A1 (de) 2002-11-06
EP1121926A1 (de) 2001-08-08
EP1121926A9 (de) 2002-01-16
JP2003521505A (ja) 2003-07-15
BR0108056A (pt) 2003-01-28
AU4411101A (en) 2001-08-14
KR100748056B1 (ko) 2007-08-09
EP1253906B1 (de) 2004-10-27
DE50104294D1 (de) 2004-12-02
US20030152536A1 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
EP1303255A1 (de) Verwendung eine synergistisch wirkende mischung welche das haarwachstum inhibiert
EP1239826A2 (de) Kosmetische und/oder pharmazeutische zubereitungen
EP1253904A2 (de) Extrakte von rückständen aus der weinherstellung
EP1351662A1 (de) Kosmetische und/oder pharmazeutische zubereitungen
EP1260212A1 (de) Kosmetische Mittel
EP1284133A1 (de) Wirkstoffmischungen
DE10160682A1 (de) Emollients und kosmetische Zusammensetzungen
EP1272155A1 (de) Verwendung von naturstoffen zur herstellung von kosmetischen zubereitungen
EP1257253A2 (de) Kosmetische zubereitungen enthaltend pflanzenextrakte
EP1253906B1 (de) Kosmetische zubereitungen mit waltheria indica extrakten und ferulasäure
EP1213024A1 (de) Kosmetische und/oder dermopharmazeutische Zubereitungen enthaltend native Proteine aus der Pflanze Argania spinosa
EP1485061A1 (de) ÖLPHASEN FüR KOSMETISCHE MITTEL
EP1441747A2 (de) Verwendung eines extraktes der vigna aconitifolia-pflanze in einer kosmetischen und/oder dermopharmazeutischen zusammensetzung
WO2001082885A1 (de) Kosmetische und/oder pharmazeutische zubereitungen enthaltend einen extrakt der pflanze argania spinosa
DE10254315A1 (de) Emollients und kosmetische Zubereitungen
EP1239814A2 (de) Kosmetische verwendung von ruckstanden aus der weinherstellung
WO2001074302A1 (de) Pro-liposomal verkapselte zubereitungen
EP1421929A2 (de) Emollients und kosmetische Zubereitungen
DE10160681A1 (de) Emollients und kosmetische Zusammensetzungen
WO2001052809A1 (de) Kosmetische und/oder pharmazeutische zubereitungen enthaltend eine wirksame menge eines extraktes von arrabidaea chica
EP1499282A2 (de) Anti-ageingmittel pflanzenextrakte der gattung arctium enthaltend
DE19934130A1 (de) Kosmetische Mittel enthaltend Hydroxychavicol
DE19943585A1 (de) Ölkörpermischung
EP1292278A2 (de) Zubereitungen enthaltend einen extrakt der pflanze pistia stratiotes
DE19933857A1 (de) Kosmetische Mittel mit Pflanzenextrakten

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AU AZ BA BB BG BR BY BZ CA CN CR CU CZ DM DZ EE GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LV MA MD MG MK MN MW MX MZ NO NZ PL RO RU SD SG SI SK SL TJ TM TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001916957

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 556233

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 018046533

Country of ref document: CN

Ref document number: 1020027010186

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2001916957

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10203228

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1020027010186

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 2001916957

Country of ref document: EP